141 related articles for article (PubMed ID: 6150862)
1. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
Hicks PE; Schoemaker H; Langer SZ
Eur J Pharmacol; 1984 Oct; 105(3-4):339-42. PubMed ID: 6150862
[TBL] [Abstract][Full Text] [Related]
2. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
Bischoff S; Heinrich M; Sonntag JM; Krauss J
Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.
Bischoff S; Heinrich M; Krauss J; Sills MA; Williams M; Vassout A
J Recept Res; 1988; 8(1-4):107-20. PubMed ID: 3290470
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
Riddall DR
Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
[TBL] [Abstract][Full Text] [Related]
5. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors.
Ohlstein EH; Berkowitz BA
Eur J Pharmacol; 1985 Jan; 108(2):205-8. PubMed ID: 3884345
[TBL] [Abstract][Full Text] [Related]
6. Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro.
Hilditch A; Drew GM
Eur J Pharmacol; 1985 Oct; 116(1-2):171-4. PubMed ID: 2865160
[TBL] [Abstract][Full Text] [Related]
7. [3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
De Keyser J; Walraevens H; Convents A; Ebinger G; Vauquelin G
Eur J Pharmacol; 1989 Mar; 162(3):437-45. PubMed ID: 2568263
[TBL] [Abstract][Full Text] [Related]
8. Typical and atypical antipsychotic drugs are potent antagonists of the relaxant 5-hydroxytryptamine receptor in the smooth muscle of canine coronary artery.
Terrón JA
Proc West Pharmacol Soc; 1996; 39():23-5. PubMed ID: 8895957
[No Abstract] [Full Text] [Related]
9. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
McQuade RD; Ford D; Duffy RA; Chipkin RE; Iorio LC; Barnett A
Life Sci; 1988; 43(23):1861-9. PubMed ID: 2904635
[TBL] [Abstract][Full Text] [Related]
10. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
Apud JA; Masotto C; Ongini E; Racagni G
Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
[TBL] [Abstract][Full Text] [Related]
11. [3H]SCH 23390 labels dopamine D-1 receptor sites in the rat kidney.
Zdilar D; Lacković Z
Eur J Pharmacol; 1989 May; 164(1):159-62. PubMed ID: 2568936
[TBL] [Abstract][Full Text] [Related]
12. SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity.
Skarsfeldt T; Larsen JJ
Eur J Pharmacol; 1988 Apr; 148(3):389-95. PubMed ID: 2968272
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist.
Blackburn TP; Thornber CW; Pearce RJ; Cox B
Eur J Pharmacol; 1988 Jun; 150(3):247-56. PubMed ID: 3416910
[TBL] [Abstract][Full Text] [Related]
14. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
Tedford CE; Crosby G; Iorio LC; Chipkin RE
Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
Andersen PH
Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
19. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
[TBL] [Abstract][Full Text] [Related]
20. The relaxant 5-HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5-ht7 receptor subtype.
Terrón JA
Br J Pharmacol; 1996 Jul; 118(6):1421-8. PubMed ID: 8832067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
